2004
DOI: 10.1073/pnas.0308302101
|View full text |Cite
|
Sign up to set email alerts
|

Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration

Abstract: Recessive Stargardt's macular degeneration is a blinding disease of children caused by mutations in the ABCA4 (ABCR) gene. Mice with a knockout mutation in abcr accumulate toxic lipofuscin pigments in ocular tissues, similar to affected humans. The major fluorophore of lipofuscin is the bis-retinoid, N-retinylidene-N-retinylethanolamine (A2E). In the current study, we sought to define the effect of increasing light on A2E accumulation. We crossed the abcr Ϫ/Ϫ mutation onto an albino background. The retinoid pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
119
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 149 publications
(131 citation statements)
references
References 44 publications
6
119
0
Order By: Relevance
“…Photoaffinity labeling of Abca4 -/-retinas ( Figure 3B in a murine model of rSTGD. Targeted disruption of the Abca4 locus in pigmented (22) and albino (23) mice (Abca4 -/-) results in a phenotype that recapitulates some rSTGD characteristics: accumulation of lipofuscin in the RPE, thicker RPE cells, slow photoreceptor degeneration, and delayed dark adaptation (22)(23)(24). To test whether rAAV2/5-mediated gene delivery results in correction of the Abca4 -/-mutant phenotype, 1-month-old mice were injected subretinally with 2 μl of rAAV2/5-CMV-Abca4 (corresponding to 1.2 × 10 9 GC) in one eye and with the same dose of rAAV2/5-CMV-EGFP in the contralateral eye.…”
Section: Resultsmentioning
confidence: 99%
“…Photoaffinity labeling of Abca4 -/-retinas ( Figure 3B in a murine model of rSTGD. Targeted disruption of the Abca4 locus in pigmented (22) and albino (23) mice (Abca4 -/-) results in a phenotype that recapitulates some rSTGD characteristics: accumulation of lipofuscin in the RPE, thicker RPE cells, slow photoreceptor degeneration, and delayed dark adaptation (22)(23)(24). To test whether rAAV2/5-mediated gene delivery results in correction of the Abca4 -/-mutant phenotype, 1-month-old mice were injected subretinally with 2 μl of rAAV2/5-CMV-Abca4 (corresponding to 1.2 × 10 9 GC) in one eye and with the same dose of rAAV2/5-CMV-EGFP in the contralateral eye.…”
Section: Resultsmentioning
confidence: 99%
“…Whereas chronic light exposures are difficult to quantify in human patients, experimental animal models have provided convincing evidence in support of this notion (Radu et al, 2004;Vaughan et al, 2003). Noteworthy in this regard is the recent report by Cideciyan and colleagues (2005), regarding a naturally occurring canine model of retinitis pigmentosa, in which they stated that 'modest light levels, as used in routine clinical practice, dramatically accelerated the neurodegeneration', leading those authors to call for 'a genespecific clinical trial of light reduction in human rhodopsin disease'.…”
Section: Introductionmentioning
confidence: 99%
“…This pyridinium bisretinoid pathway is more active under conditions of elevated concentrations of ATR, circumstances that likely include dysfunction of the ABCA4 (ABCR) transporter, the latter being the protein product of the Stargardt's disease gene (20). Other modulations of pyridinium bisretinoid pathway are levels of illumination (17,18,21) and the kinetics of the retinoid cycle (22).Since A2E was characterized (14, 15), several consequences of its accumulation have been reported. Because of its amphiphilic properties, A2E can exert detergent-like effects on cell membranes (23-26), perturb lysosomal function (27, 28), and mediate blue-light damage (29-31).…”
mentioning
confidence: 99%
“…This pyridinium bisretinoid pathway is more active under conditions of elevated concentrations of ATR, circumstances that likely include dysfunction of the ABCA4 (ABCR) transporter, the latter being the protein product of the Stargardt's disease gene (20). Other modulations of pyridinium bisretinoid pathway are levels of illumination (17,18,21) and the kinetics of the retinoid cycle (22).…”
mentioning
confidence: 99%